Skip to main content

Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment.

Publication ,  Journal Article
Leonardi, RA; Kransdorf, EP; Simel, DL; Wang, A
Published in: Circ Cardiovasc Interv
April 2010

BACKGROUND: Septal reduction for obstructive hypertrophic cardiomyopathy may be performed by surgical myectomy or alcohol septal ablation (ASA). Unlike surgical myectomy, ASA creates an intramyocardial scar that may potentiate the risk of ventricular arrhythmias and sudden cardiac death (SCD). METHODS AND RESULTS: Systematic reviews for ASA and surgical myectomy were performed. Study selection and data extraction were completed independently by 2 investigators. Comparative data analyses were completed using a random effects model and regression analysis. Kappa statistics for agreement on initial study inclusion were high for both ASA (0.78; 95% CI, 0.68 to 0.88) and surgical myectomy studies (0.95; 95% CI, 0.84 to 1.0). Nineteen ASA studies (2207 patients) and 8 surgical myectomy studies (1887 patients) were included. Median follow-up was shorter for ASA than for myectomy studies (51 versus 1266 patient-years; P<0.001). For ASA and surgical myectomy, unadjusted rates (events/patient-years) of all-cause mortality (0.021 versus 0.018, respectively; P=0.37) and SCD (0.004 versus 0.003, respectively; P=0.36) were similar. Patients treated with ASA were older (weighted mean, 55 versus 44 years; P<0.001) and had less septal hypertrophy (weighted mean, 21 versus 23 mm; P<0.001) compared with those treated with myectomy. After adjustment for available baseline characteristics, odds ratios for treatment effect on all-cause mortality and SCD were 0.28 (95% CI, 0.16 to 0.46) and 0.32 (95% CI, 0.11 to 0.97), respectively, favoring ASA. CONCLUSIONS: Rates of all-cause mortality and SCD after both ASA and surgical myectomy were similarly low. Adjusted for baseline characteristics, the odds ratios for treatment effect on all-cause mortality and SCD were lower in ASA cohorts compared with surgical myectomy cohorts.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circ Cardiovasc Interv

DOI

EISSN

1941-7632

Publication Date

April 2010

Volume

3

Issue

2

Start / End Page

97 / 104

Location

United States

Related Subject Headings

  • Regression Analysis
  • Humans
  • Heart Septum
  • Female
  • Ethanol
  • Death, Sudden, Cardiac
  • Cause of Death
  • Cardiovascular System & Hematology
  • Cardiomyopathy, Hypertrophic
  • Arrhythmias, Cardiac
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Leonardi, R. A., Kransdorf, E. P., Simel, D. L., & Wang, A. (2010). Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment. Circ Cardiovasc Interv, 3(2), 97–104. https://doi.org/10.1161/CIRCINTERVENTIONS.109.916676
Leonardi, Robert A., Evan P. Kransdorf, David L. Simel, and Andrew Wang. “Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment.Circ Cardiovasc Interv 3, no. 2 (April 2010): 97–104. https://doi.org/10.1161/CIRCINTERVENTIONS.109.916676.
Leonardi, Robert A., et al. “Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment.Circ Cardiovasc Interv, vol. 3, no. 2, Apr. 2010, pp. 97–104. Pubmed, doi:10.1161/CIRCINTERVENTIONS.109.916676.

Published In

Circ Cardiovasc Interv

DOI

EISSN

1941-7632

Publication Date

April 2010

Volume

3

Issue

2

Start / End Page

97 / 104

Location

United States

Related Subject Headings

  • Regression Analysis
  • Humans
  • Heart Septum
  • Female
  • Ethanol
  • Death, Sudden, Cardiac
  • Cause of Death
  • Cardiovascular System & Hematology
  • Cardiomyopathy, Hypertrophic
  • Arrhythmias, Cardiac